You're clearly a company sympathiser and overcomplicating the situation.
Its great that you think all those reasons should be cause for the GoG to approve the exploitation license, but reality is there is absolutely no evidence that even remotely suggests the GoG are going to change their stance due to any of the reasons you outlined. Its simply just your opinions, which don't account for much, although I'm sure there's some desperate SH's who would think otherwise.
In the mean time, what do SH's have to look forward too. The arbitration process could take up to 12 months or more to play out and the GoG will more than likely reject GGG exploitation license within 5-6 months. It really is dire situation.
" GML were negotiating with EU processing before all this started.... Further we are not at war with China and they dominate everything as you should know...."
GGG current business plan is to supply a low grade, mixed concentrate to China, because China was the only country interested. Point out to me where any of the EU nations, or anyone besides China, have even mentioned they would be interested in building a processing plant for GGG concentrate. That's great that GGG were in negotiations with EU processing, means absolutely nothing.
- Forums
- ASX - By Stock
- ETM
- Naaja lifts her head above the trench, cops friendly fire
Naaja lifts her head above the trench, cops friendly fire, page-53
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ETM (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2053 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 499999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2053 | 0.025 |
1 | 10000 | 0.022 |
2 | 224534 | 0.020 |
10 | 3867745 | 0.019 |
8 | 2685226 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 499999 | 1 |
0.021 | 100000 | 1 |
0.022 | 536181 | 4 |
0.023 | 235000 | 1 |
0.024 | 162542 | 2 |
Last trade - 08.36am 16/07/2024 (20 minute delay) ? |
Featured News
ETM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online